Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $231

Benzinga Newsdesk www.benzinga.com Positive 81.8%

Neg 0% Neu 0% Pos 81.8%

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $213 to $231.